Extended Anticoagulant Treatment with Full- or Reduced-Dose Apixaban in Patients with Cancer-Associated Venous Thromboembolism: Rationale and Design of the API-CAT Study
暂无分享，去创建一个
E. Vicaut | A. Torbicki | C. Samama | O. Mir | A. Maraveyas | S. Laporte | P. Verhamme | S. Szmit | C. Chapelle | G. Agnelli | M. Monreal | A. Bamias | M. Huisman | P. Girard | K. Syrigos | G. Meyer | A. Bamias | I. Mahé | C. Ay | M. Carrier | C. Becattini | M. Righini | Tzu‐Fei Wang | F. A. Klok | A. Cohen | D. Mayeur | K. Syrigos | J. J. López-Núñez | E. Klok | F. Klok